Helen Bixenman
San Diego Blood Bank listed Helen Bixenman as CHIEF QUALITY & REGULATION on its 2024 Form 990.
Reported compensation by filing year
Each entry comes from one tax return. Bar lengths compare reported compensation across filings.
Tax year
Reported total$288,629
- From filing organization
- $278,143
- From related organizations
- $0
- Other compensation
- $10,486
Tax year
Reported total$288,629
- From filing organization
- $278,143
- From related organizations
- $0
- Other compensation
- $10,486
Tax year
Reported total$278,310
- From filing organization
- $264,950
- From related organizations
- $0
- Other compensation
- $13,360
Tax year
Reported total$266,672
- From filing organization
- $254,103
- From related organizations
- $0
- Other compensation
- $12,569
Tax year
Reported total$270,982
- From filing organization
- $249,352
- From related organizations
- $0
- Other compensation
- $21,630
Tax year
Reported total$226,575
- From filing organization
- $219,334
- From related organizations
- $0
- Other compensation
- $7,241
Tax year
Reported total$220,081
- From filing organization
- $207,515
- From related organizations
- $0
- Other compensation
- $12,566
Tax year
Reported total$214,768
- From filing organization
- $206,118
- From related organizations
- $0
- Other compensation
- $8,650
Tax year
Reported total$179,755
- From filing organization
- $179,755
- From related organizations
- $0
- Other compensation
- $0
Tax year
Reported total$177,914
- From filing organization
- $177,914
- From related organizations
- $0
- Other compensation
- $0
Official bio
Helen Bixenman has over 30 years of significant contribution within the biotech/healthcare arena. Through key strategic roles, Helen has acquired broad-based general management experience encompassing clinical operations for multi-site, multi-million dollar operations. Areas of professional expertise encompass compliance and regulatory affairs, quality assurance and quality control, clinical research, technical administration and operations and strategic planning and business development. Before joining San Diego Blood Bank, she held positions of increasing responsibility with several clinical laboratories and healthcare systems including Phoenix Children’s Hospital, Banner Health, Sun Health, Genzyme Genetics/Genetrix and the Genetics Center of the Southwest Biomedical Research Institute. Helen currently serves as Immediate Past-President of the Association of Genetic Technologists and as a member of the American Society